Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of immunologic surrogate endpoints for varicella vaccine
CTR20241619Phase 4Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of varicella vaccine live in chickenpox, sponsored by Sinovac Biotech Ltd.. Started May 2024; status: active.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20241619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241619.